𝕽𝖔𝖉𝖓𝖊𝖞 𝕸. 𝕵𝖎𝖒𝖊𝖓𝖊𝖟, 𝕸𝕯

A/Professor, College of Medicine, UERM Medical Center🇵🇭; Past President, Philippine Heart Association; Secretary, Philippine College of Physicians

[𝕽𝖔𝖉𝖓𝖊𝖞 𝕸. 𝕵𝖎𝖒𝖊𝖓𝖊𝖟, 𝕸𝕯 @docrodney]

Sana naman may kahihinatnan itong DPWH-Congress-Senate brouhaha na ito. Baka mauwi na naman sa estilo ni Napoles — parehong-pareho, pero mas marami lang ngayon ang sangkot. Noon nga sa Pork Barrel Scam, wala namang nakulong. Kung seryoso talaga ang gobyerno sa kanilang paunang palabas, dapat may managot. Kapag tapos na ito at may nanagot na, ibang ahensya na naman tulad ng Customs, LGUs ang ungkatin.

Huwag natin gawing normal ang corruption. Gawin nating “kadiri!”

[𝕽𝖔𝖉𝖓𝖊𝖞 𝕸. 𝕵𝖎𝖒𝖊𝖓𝖊𝖟, 𝕸𝕯 @docrodney]

Pawis at dugo ng taumbayan—nauuwi lang sa bulsa ng iilan.
Tama na! Sobra na!

[𝕽𝖔𝖉𝖓𝖊𝖞 𝕸. 𝕵𝖎𝖒𝖊𝖓𝖊𝖟, 𝕸𝕯 @docrodney]

Huwag na tayong paloko. Magsalita tayo—because the only thing necessary for the triumph of evil is for good men to do nothing.

[𝕽𝖔𝖉𝖓𝖊𝖞 𝕸. 𝕵𝖎𝖒𝖊𝖓𝖊𝖟, 𝕸𝕯 @docrodney]

🇵🇭 Nalulunod sa baha ang Pilipino,
habang naliligo sa luho ang corrupt.

Kung malakas sila,
👉 Mas malakas tayo!

📢 Sama-sama tayong manindigan para sa tama.

[Philippine Heart Association @PhilHeartAssoc]

Stopping Rheumatic Heart Disease starts with awareness, early detection, and united action.”
– Dr. Aurora Muriel S. Gamponia, VP, PHA 🇵🇭❤️ #RHD #ESC2025 #Cardiology #ESCCongress
@escardio

[𝕽𝖔𝖉𝖓𝖊𝖞 𝕸. 𝕵𝖎𝖒𝖊𝖓𝖊𝖟, 𝕸𝕯 @docrodney]

🫀 Obesity is more than “just weight” — it’s a chronic disease.
❌ Fat in the wrong places (ectopic fat) can harm your heart and other organs.
⚠️ Dysfunctional fat = multiple health problems that worsen each other.
👩‍⚕️ People with obesity often have other conditions that add to the burden.
✅ Prevention is key — stopping fat-related damage early helps protect your heart later in life.

Remember: Obesity is a disease. Prevention saves lives. ❤️

#ESC2025

[𝕽𝖔𝖉𝖓𝖊𝖞 𝕸. 𝕵𝖎𝖒𝖊𝖓𝖊𝖟, 𝕸𝕯 @docrodney]

Hindi lahat ng chest pain ay nangangailangan agad ng procedure.

Pero may mga sitwasyon na mas ligtas at mas epektibo kung susuriin at bubuksan ang ugat ng puso:
✔️ Kapag may heart attack
✔️ Kung may stable angina na hindi kontrolado ng gamot
✔️ Kapag may sintomas na malubha tulad ng heart failure o arrhythmia
✔️ Bago ang ilang heart surgeries
✔️ Pagkatapos ng sudden cardiac arrest

Tandaan: Hindi lahat ng “ischemia” o “block” sa ECG ay automatic angiogram.

⚠️ Disclaimer:
Ilan lamang ito sa mga karaniwang dahilan kung bakit nirerekomenda ang angiogram o angioplasty.

May iba pang sitwasyon depende sa findings at kondisyon ng pasyente.

Laging kumonsulta sa inyong cardiologist para sa tamang payo.

[Philippine Heart Association @PhilHeartAssoc]

You can’t control the stressor, pero kaya mong kontrolin ang reaction mo. Choose peace, choose puso. ♥️

#PHAPusoMuna #umiwassastress

[Philippine Heart Association @PhilHeartAssoc]

𝙈𝙖𝙩𝙪𝙡𝙤𝙜 𝙣𝙜𝙖 𝙆𝙪𝙢𝙥𝙡𝙚𝙩𝙤 (7-9 𝙣𝙖 𝙤𝙧𝙖𝙨)

Masarap mag-series marathon… pero worth it ba kung eyebags, puyat, at puso ang kapalit? 😴♥️

#MatulogNangKumpleto #PHAPusoMuna

[Philippine Heart Association @PhilHeartAssoc]

PhilHealth AMI Package is here! ♥️

After 6 years of advocacy, heart attack patients can now access lifesaving treatments like angioplasty & fibrinolysis in accredited hospitals.

✅ No Balance Billing for indigents
✅ Quality care, no financial burden

#PHA #PSCCI #PCEM #AIHO

[Philippine Heart Association @PhilHeartAssoc]

Sugar ay Kontrolin

Real talk: Tubig lang, sapat na.
Masarap ang matatamis na inumin, oo — pero puwede itong magdulot ng dagdag timbang, diabetes, at mas mataas na panganib sa sakit sa puso.
‘Wag magpadala sa hype — mas cool pa rin ang healthy.

#PHAPusoMuna

[Philippine Heart Association @PhilHeartAssoc]

𝙊𝙗𝙚𝙨𝙞𝙩𝙮 𝙖𝙮 𝙞𝙬𝙖𝙨𝙖𝙣.

Kumuha lang ng sapat,
para timbang ay ‘di sumasapaw sa lahat.

Hindi sayang ang tira,
kung puso at buhay ang laging masigla. 💖🍚

#PHAPusoMuna #obesityayiwasan

[𝕽𝖔𝖉𝖓𝖊𝖞 𝕸. 𝕵𝖎𝖒𝖊𝖓𝖊𝖟, 𝕸𝕯 @docrodney]

3/3

𝙒𝙝𝙮 𝘿𝙤𝙘𝙩𝙤𝙧𝙨’ 𝙋𝙁𝙨 𝙎𝙥𝙖𝙧𝙠 𝘿𝙚𝙗𝙖𝙩𝙚

Don’t Blame the Healer, Fix the System.

There is so much to unpack here.

[𝕽𝖔𝖉𝖓𝖊𝖞 𝕸. 𝕵𝖎𝖒𝖊𝖓𝖊𝖟, 𝕸𝕯 @docrodney]

1/3

𝙒𝙝𝙮 𝘿𝙤𝙘𝙩𝙤𝙧𝙨’ 𝙋𝙁𝙨 𝙎𝙥𝙖𝙧𝙠 𝘿𝙚𝙗𝙖𝙩𝙚

Don’t Blame the Healer, Fix the System.

There is so much to unpack here.

[𝕽𝖔𝖉𝖓𝖊𝖞 𝕸. 𝕵𝖎𝖒𝖊𝖓𝖊𝖟, 𝕸𝕯 @docrodney]

2/3

𝙒𝙝𝙮 𝘿𝙤𝙘𝙩𝙤𝙧𝙨’ 𝙋𝙁𝙨 𝙎𝙥𝙖𝙧𝙠 𝘿𝙚𝙗𝙖𝙩𝙚

Don’t Blame the Healer, Fix the System.

There is so much to unpack here.

[𝕽𝖔𝖉𝖓𝖊𝖞 𝕸. 𝕵𝖎𝖒𝖊𝖓𝖊𝖟, 𝕸𝕯 @docrodney]

#Day2 #ACC25 Summary by @DFCapodanno

[Davide Capodanno @DFCapodanno]

#ACC25 Day 2, here is the summary of today’s trials (I haven’t included the follow-up extensions of Evolut Low Risk, Triluminate, and FAME 3). Today, I counted at least 2 NEJM, 4 Lancet, 1 Nature, 1 JAMA, 1 Circulation, and 1 JACC.

1. MIGHTy-Heart = In-home paramedic visits for heart failure did not reduce 30-day readmissions or improve health status compared to standard follow-up calls.
2. FRESH-UP = Limiting fluid intake showed no benefit for heart failure in the outpatient setting.
3. EQUIOX = Pulse oximeter readings differed significantly between patients with dark and light skin, compared to arterial blood oxygen saturation.
4. FAIR-HF2 = Intravenous iron with ferric carboxymaltose improved quality of life in HFrEF with iron deficiency but did not reduce heart failure hospitalizations or cardiovascular death.
5. BHF PROTECT-TAVI = Cerebral embolic protection during TAVI did not reduce stroke incidence within 72 hours.
6. ALIGN-AR = TAVR with the Trilogy valve in aortic regurgitation showed a 1-year mortality rate of 8.1%, well below the 25% noninferiority goal.
7. FLAVOUR II = AngioFFR, an AI-powered FFR method, was noninferior to IVUS in PCI outcomes for patients with significant stenosis.
8. SMART-CHOICE 3 = Clopidogrel monotherapy was more effective than aspirin in reducing major adverse cardiac and cerebrovascular events after PCI.
9. ALLEPRE = A secondary prevention program with counseling on heart medications and lifestyle changes reduced the primary composite outcome at five years post-ACS.
10. ALPACA = Lepodisiran, an extended-duration, small interfering RNA, reduced lipoprotein(a) concentrations in participants with elevated levels.

[𝕽𝖔𝖉𝖓𝖊𝖞 𝕸. 𝕵𝖎𝖒𝖊𝖓𝖊𝖟, 𝕸𝕯 @docrodney]

Good Summary by @DFCapodanno #ACC25 #firstday

[Davide Capodanno @DFCapodanno]

First day at #ACC25, here are the results of 10 trials presented today. I counted 3 NEJM, 1 Lancet, and 1 JAMA.

WARRIOR: Intensive medical therapy did not reduce major CV events at five years in women with suspected INOCA.
STRIDE: Semaglutide improved walking distance, symptoms, and quality of life in PAD with diabetes.
API-CAT: Low-dose apixaban was noninferior to full-dose for preventing VTE recurrence in cancer patients.
RIVAWAR: Rivaroxaban was as effective and safe as warfarin for post-MI LV thrombus resolution at three months.
FARES-II: Four-factor PCC was superior to frozen plasma for bleeding control in cardiac surgery.
REVERSE-IT: Bentracimab reversed ticagrelor’s antiplatelet effects in urgent surgery or major bleeding.
HOST-BR: Three-month DAPT reduced adverse events without more bleeding vs. one-month in high-bleeding-risk patients post-stent.
SOUL: Oral semaglutide reduced MACE by 14% over four years with no safety concerns.
ADVANCE-HTN: Lorundrostat significantly lowered systolic BP at 12 weeks in uncontrolled hypertension.
DAPA-TAVI: Dapagliflozin reduced mortality and heart failure worsening post-TAVI vs. standard care.

[𝕽𝖔𝖉𝖓𝖊𝖞 𝕸. 𝕵𝖎𝖒𝖊𝖓𝖊𝖟, 𝕸𝕯 @docrodney]

DapaTAVI Trial: Dapagliflozin significantly reduced mortality and heart failure worsening in high-risk older adults undergoing transcatheter aortic valve implantation (TAVI). Among patients with heart failure and additional comorbidities—such as renal insufficiency, diabetes, or left ventricular systolic dysfunction—the SGLT2 inhibitor lowered the 1-year risk of all-cause death or heart failure–related hospitalization/urgent care compared to standard therapy (15.0% vs 20.1%; HR 0.72, 95% CI 0.55–0.95; P=0.02).

#ACC25

[𝕽𝖔𝖉𝖓𝖊𝖞 𝕸. 𝕵𝖎𝖒𝖊𝖓𝖊𝖟, 𝕸𝕯 @docrodney]

#ScienceEvolves

[𝕽𝖔𝖉𝖓𝖊𝖞 𝕸. 𝕵𝖎𝖒𝖊𝖓𝖊𝖟, 𝕸𝕯 @docrodney]

Smiling doesn’t just make you look good—it makes you feel good.